MY152169A - Human anti-b7rp1 neutralizing antibodies - Google Patents

Human anti-b7rp1 neutralizing antibodies

Info

Publication number
MY152169A
MY152169A MYPI20080045A MY152169A MY 152169 A MY152169 A MY 152169A MY PI20080045 A MYPI20080045 A MY PI20080045A MY 152169 A MY152169 A MY 152169A
Authority
MY
Malaysia
Prior art keywords
b7rp1
antibodies
neutralizing antibodies
human anti
bind
Prior art date
Application number
Inventor
Gerald Siu
Wenyan Shen
Steven Kiyoshi Yoshinaga
Haichun Huang
Original Assignee
Medarex Llc
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medarex Llc, Amgen Inc filed Critical Medarex Llc
Priority to MYPI20080045 priority Critical patent/MY152169A/en
Publication of MY152169A publication Critical patent/MY152169A/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

THIS INVENTION PROVIDES ANTIBODIES THAT INTERACT WITH OR BIND TO HUMAN B7 RELATED PROTEIN-1 (B7RP1) AND ANTIBODIES THAT BIND TO AND NEUTRALIZE THE FUNCTION OF B7RP1 THEREBY. THE INVENTION ALSO PROVIDES PHARMACEUTICAL COMPOSITIONS OF SAID ANTIBODIES AND METHODS FOR NEUTRALIZING B7RP1 FUNCTION, AND PARTICULARLY FOR TREATING IMMUNE DISORDERS (E.G., INAPPROPRIATE IMMUNE RESPONSE) BY ADMINISTERING A PHARMACEUTICALLY EFFECTIVE AMOUNT OF ANTI-B7RP1 ANTIBODIES. METHODS OF DETECTING THE AMOUNT OF B7RP1 IN A SAMPLE USING ANTI-B7RP1 ANTIBODIES ARE ALSO PROVIDED.
MYPI20080045 2008-01-09 2008-01-09 Human anti-b7rp1 neutralizing antibodies MY152169A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI20080045 MY152169A (en) 2008-01-09 2008-01-09 Human anti-b7rp1 neutralizing antibodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI20080045 MY152169A (en) 2008-01-09 2008-01-09 Human anti-b7rp1 neutralizing antibodies

Publications (1)

Publication Number Publication Date
MY152169A true MY152169A (en) 2014-08-15

Family

ID=52595862

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20080045 MY152169A (en) 2008-01-09 2008-01-09 Human anti-b7rp1 neutralizing antibodies

Country Status (1)

Country Link
MY (1) MY152169A (en)

Similar Documents

Publication Publication Date Title
SG164369A1 (en) Human anti-b7rp1 neutralizing antibodies
MX350200B (en) Human antibodies and antibody-drug conjugates against cd74.
EA201270815A1 (en) ESTROGEN RECEPTOR MODULATORS AND THEIR APPLICATION
MY158560A (en) Composition comprising antiboby that binds to domain ii of her2 and acidic variants thereof
MTP4289B (en) Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
MY166776A (en) Humanised anti-ctla4 antibodies
UA109633C2 (en) HUMAN ANTIBODY AGAINST TISSUE FACTOR
UA106194C2 (en) Diagnosis and treatment of cancer using anti-ereg antibody
UA92505C2 (en) Anti-cd3 antibody formulations
WO2008105886A3 (en) HUMANIZED FCγRIIB-SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF
MX2011000255A (en) Combination of a c-met antagonist and an aminoheteroaryl compound for the treatment of cancer.
WO2010008831A3 (en) Compounds and methods for modulating g protein-coupled receptors
EA201070636A1 (en) INHIBITION OF THE PROTECTOR PROTEIN, STIMULATING MACROPHAGE (RON), AND METHODS OF ITS TREATMENT
WO2009082038A3 (en) Ampa receptor antagonists and zonisamide for epilepsy
WO2009142738A3 (en) Compositions and methods for diagnosing and treating cancer
WO2011025978A3 (en) Methods of treatment using anti-oxidized ldl antibodies
MY152169A (en) Human anti-b7rp1 neutralizing antibodies
MY185086A (en) Human anti-b7rp1 neutralizing antibodies
WO2008118324A3 (en) Composition and method of treating cancer with an anti-uroplakin ib antibody
CY1117637T1 (en) HUMAN ANTI-B7RP1 CONTROLLED ANTIBODIES
MX2009002717A (en) Compositions and methods for treatment of chronic fatigue syndrome and neurodegenerative diseases.
UA104144C2 (en) Combination of a c-met antagonist and an aminoheteroaryl compound for the treatment of cancer
UA97645C2 (en) Antibody which binds human il-6 receptor
TN2010000611A1 (en) Combination of a c-met antagonist and an aminoheteroaryl compound for the treatment of cancer
UA109423C2 (en) COMPOSITION AND METHOD FOR TUMOR DIAGNOSTICS AND TREATMENT